Author

S. Rajasekaran

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

N. Gajendran· 2 shared S. N. Witt· 2 shared L. Chesnokova· 1 shared S. Cheng· 1 shared S. Shekoohi· 1 shared X. Yu· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

N. Gajendran

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transcriptomic analysis of melanoma cells reveals an association of α-synuclein with regulation of the inflammatory response.

S. Rajasekaran, S. Cheng, N. Gajendran, S. Shekoohi, L. Chesnokova, X. Yu, S. N. Witt

This study identifies α-synuclein's role in regulating inflammatory gene expression in melanoma cells through RNA sequencing and validation.

bioRxiv · Dec 23, 2023Cancer Biology

Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility

N. Gajendran, S. Rajasekaran, S. N. Witt

This study shows that knocking out alpha-synuclein in melanoma cells reduces L1CAM expression and motility, suggesting a pro-survival role for alpha-synuclein in melanoma.

bioRxiv · Jan 17, 2023Cancer Biology